Eagle Pharmaceuticals/ US2697961082 /
2024-04-24 5:12:31 PM | Chg. -0.11 | Volume | Bid5:12:31 PM | Ask5:12:31 PM | High | Low |
---|---|---|---|---|---|---|
4.67USD | -2.30% | 1,961 Turnover: 9,200.41 |
4.63Bid Size: 200 | 4.71Ask Size: 200 | 4.79 | 4.66 |
GlobeNewswire
04-15
Eagle Pharmaceuticals to Present Additional Data from Phase III Trial Demonstrating Sustained Respon...
GlobeNewswire
04-12
Eagle Pharmaceuticals Announces Receipt of Notification of Deficiency from Nasdaq Regarding Requirem...
GlobeNewswire
02-11
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Eagle Pharmaceu...
GlobeNewswire
02-09
EGRX DEADLINE TOMORROW: ROSEN, A HIGHLY RECOGNIZED LAW FIRM, Encourages Eagle Pharmaceuticals, Inc. ...
GlobeNewswire
02-08
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Eagle Pharmaceuticals, Inc.(EGRX) Investors of a Class ...
GlobeNewswire
02-08
EAGLE PHARMACEUTICALS 48 HOUR DEADLINE ALERT: Faruqi & Faruqi Securities Litigation Partner James (J...
GlobeNewswire
02-08
EGRX FINAL DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Eagle Pharmaceuticals...
GlobeNewswire
02-05
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Eagle Pharmaceuticals, Inc.(EGRX) Investors of a Class ...
GlobeNewswire
02-05
DEADLINE ALERT for GM, EGRX, MRCY, and ON: The Law Offices of Frank R. Cruz Reminds Investors of Cla...
GlobeNewswire
02-05
DEADLINE ALERT for EGRX, ON, MRCY, LOVE: Law Offices of Howard G. Smith Reminds Investors of Class A...
GlobeNewswire
02-05
Eagle Pharmaceuticals (EGRX) Tells SEC It Improperly Accounted for Past Two Quarters and Defaults on...
GlobeNewswire
02-05
Holzer & Holzer, LLC Reminds Investors of February 9, 2024 Lead Plaintiff Deadline in Eagle Pharmace...
GlobeNewswire
02-05
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Eag...
GlobeNewswire
02-04
ROSEN, NATIONAL TRIAL COUNSEL, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Be...
GlobeNewswire
02-03
SHAREHOLDER ALERT: Pomerantz Law Firm Announces the Filing of a Class Action Against Eagle Pharmaceu...
GlobeNewswire
02-02
ROSEN, A LEADING LAW FIRM, Encourages Eagle Pharmaceuticals, Inc. Investors to Secure Counsel Before...
GlobeNewswire
02-01
EAGLE PHARMACEUTICALS INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi Securities Litigation Partner J...
GlobeNewswire
02-01
Eagle Pharmaceuticals (EGRX) Tells SEC It Improperly Accounted for Past Two Quarters and Defaults on...
GlobeNewswire
02-01
SHAREHOLDER ALERT: Levi & Korsinsky Notifies Eagle Pharmaceuticals, Inc.(EGRX) Investors of a Class ...
GlobeNewswire
02-01
Glancy Prongay & Murray LLP Reminds Investors of Looming Deadline in the Class Action Lawsuit Agains...
GlobeNewswire
02-01
Bragar Eagel & Squire, P.C. Reminds Investors That Class Action Lawsuits Have Been Filed Against Mic...
GlobeNewswire
01-31
DEADLINE ALERT for GM, EGRX, MRCY, and ON: The Law Offices of Frank R. Cruz Reminds Investors of Cla...
GlobeNewswire
01-29
EGRX 11-DAY DEADLINE ALERT: Hagens Berman, National Trial Attorneys, Encourages Eagle Pharmaceutical...